Loading…
Lower Health Insurance Deductibles Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Lower Health Insurance Deductibles Act This bill modifies eligibility requirements of Health Savings Accounts (HSAs) to allow a high deductible health plan to divide the amount of its deductible between medical and drug costs.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2020 · fourth_quarter · Taxation/Internal Revenue Code
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
H.R. 3709 - Chronic Disease Management Act of 2019 - Blumenauer - HSAs and HDHPs H.R. 4651 - American Future Healthcare Act of 2019 - King - amends the Internal Revenue Code to expand health savings accounts H.R. 4652 - Individual Health Insurance Marketplace Improvement Act - Langevin - Individual Market Reinsurance fund H.R. 5807 - Know Your Provider Act of 2020 - Larson - provider directory information H.R. 5809 - Better Information Act of 2020 - Beyer - health insurance membership card H.R. 5816 - Continuing Care for Patients Act of 2020 - Moore - coverage and provider network status H.R. 5817 - Fair and Honest Advance Cost Estimate for Patients Act of 2020 - Nunes - health plan transparency H.R. 5825 - To amend the Internal Revenue Code of 1986 to provide for reporting by certain investors with respect to certain specified medical care providers - Neal - investment in medicine H.R. 6286 - Health Savings Act of 2020 - Burgess - health savings account H.R. 6545 - Health Insurance Marketplace Affordability Act of 2020 - Murphy - age rating adjustment H.R. 7008 - Family Savings Flexibility Act - Wenstrup - HSA arrangements H.R. 7825 - Pandemic Eradication and Enhanced Prevention through Savings Act - Buck - increase opportunities for savings to HSA, MSA, FSA plans H.R. 8032 - Health Savings Accounts For All Act of 2020 - Biggs - eliminate limitations on contributions to HSAs H.R. 8473 - To amend the Internal Revenue Code of 1986 to consolidate health accounts into Medisave Accounts - Gonzales - creates tax exempt Medisave accounts for qualified medical expenses H.R. 9051 - Caring for Americans with Supplemental Help Act of 2020 - Neal - increase COVID-19 recovery rebates S. 3439 - Lower Health Insurance Deductibles Act - Scott - health savings accounts S. 3539 - A bill to amend the Internal Revenue Code of 1986 to exempt telehealth services from certain high deductible health plan rules - Daines - telehealth S. 3546 - A bill to waive high deductible health plan requirements for health savings accounts - Cruz - health savings accounts S. 3924 - A bill to provide tax credits to low- to moderate-income individuals for certain computer and education costs, to direct the Federal Communications Commission to modify the requirements for the Lifeline program to provide increased support, and for other purposes. - Durbin - Lifeline/Medicaid S. 4267 - Health Savings Accounts For All Act of 2020 - Paul - eliminate limitations on contributions to HSAs S. 5085 - A bill to amend the Internal Revenue Code of 1986 to increase the additional 2020 recovery rebates, to repeal section 230 of the Communications Act of 1934 - McConnell - increase COVID-19 recovery rebates Regulatory Issues: Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate; W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; health insurer and employer reporting of health coverage; issues related to health insurance tax; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to enhancing tax treatment of long-term care insurance; issues related to qualified small employer health reimbursement accounts (QSEHRAs); issues related to implementation of the excise tax on high cost employer-sponsored health coverage; and other issues relating to health care reform implementation.
Client expense: $2,400,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Council of Economic Advisers (CEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
2020 · fourth_quarter · Consumer Issues/Safety/Products
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, the Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation) H.R. 133, the Consolidated Appropriations Act
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · fourth_quarter · Taxation/Internal Revenue Code
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, the Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation) H.R. 133, the Consolidated Appropriations Act
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 457, Health Savings Account Act H.R. 603, Heath Savings Account Expansion Act H.R. 748, Middle Class Health Benefits Tax Repeal Act of 2019 H.R. 908, Stop Penalizing Work Seniors Act Green Amendment to H.R. 1500, Consumers First Act H.R. 1679, PHIT Act of 2019 H.R. 1922, Restoring Access to Medication Act of 2019 S. 1948 / H.R. 3709, Chronic Disease Management Act of 2019 H.R. 2108, Retirement Freedom Act H.R. 2163, Freedom for Families Act H.R. 2177, Faith in Health Savings Act of 2019 H.R. 3708, Primary Care Enhancement Act of 2019 H.R. 3796, Health Savings for Senior Act H.R. 3594, Healthcare Freedom Act H.R. 4130, Keeping HSAs Accessible Act of 2019 H.R. 4530, Native American Health Savings Improvement Act H.R. 5050, Veterans and Consumers Fair Credit Act H.R. 5332, the Protecting Your Credit Score Act of 2019 S. 12, Health Savings Act of 2019 S. 680, PHIT Act of 2019 S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 1030, Retirement Freedom Act S. 1089, Restoring Access to Medication Act S. 2440, Qualified Health Savings Account Distribution Act of 2019 S. 2441, Health Savings Account Expansion Act of 2019 S. 3112, Personalized Care Act of 2019 S. 3439, Lower Health Insurance Deductibles Act S. 3546/ H.R. 6338, Pandemic Healthcare Access Act S. 4039, To amend the Internal Revenue Code of 1986 to make permanent the permissible first-dollar coverage of telehealth services for purposes of health savings accounts. H.R. 5566, Patient Fairness Act of 2020 Sections 1776 and 1812 of H.R. 6395, William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 H.R. 8478, Online Accessibility Act
Client expense: $2,940,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2020 · third_quarter · Taxation/Internal Revenue Code
H.R. 3709 - Chronic Disease Management Act of 2019 - Blumenauer - HSAs and HDHPs H.R. 4651 - American Future Healthcare Act of 2019 - King - amends the Internal Revenue Code to expand health savings accounts H.R. 4652 - Individual Health Insurance Marketplace Improvement Act - Langevin - Individual Market Reinsurance fund H.R. 5807 - Know Your Provider Act of 2020 - Larson - provider directory information H.R. 5809 - Better Information Act of 2020 - Beyer - health insurance membership card H.R. 5816 - Continuing Care for Patients Act of 2020 - Moore - coverage and provider network status H.R. 5817 - Fair and Honest Advance Cost Estimate for Patients Act of 2020 - Nunes - health plan transparency H.R. 5825 - To amend the Internal Revenue Code of 1986 to provide for reporting by certain investors with respect to certain specified medical care providers - Neal - investment in medicine H.R. 6286 - Health Savings Act of 2020 - Burgess - health savings account H.R. 6545 - Health Insurance Marketplace Affordability Act of 2020 - Murphy - age rating adjustment H.R. 7008 - Family Savings Flexibility Act - Wenstrup - HSA arrangements H.R. 7825 - Pandemic Eradication and Enhanced Prevention through Savings Act - Buck - increase opportunities for savings to HSA, MSA, FSA plans H.R. 8032 - Health Savings Accounts For All Act of 2020 - Biggs - eliminate limitations on contributions to HSAs S. 3439 - Lower Health Insurance Deductibles Act - Scott - health savings accounts S. 3539 - A bill to amend the Internal Revenue Code of 1986 to exempt telehealth services from certain high deductible health plan rules - Daines - telehealth S. 3546 - A bill to waive high deductible health plan requirements for health savings accounts - Cruz - health savings accounts S. 3924 - A bill to provide tax credits to low- to moderate-income individuals for certain computer and education costs, to direct the Federal Communications Commission to modify the requirements for the Lifeline program to provide increased support, and for other purposes. - Durbin - Lifeline/Medicaid S. 4267 - Health Savings Accounts For All Act of 2020 - Paul - eliminate limitations on contributions to HSAs Regulatory Issues: Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate; W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; health insurer and employer reporting of health coverage; issues related to implementation of health insurance tax; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to Patient-Centered Outcomes Research Institute (PCORI) re-authorization; issues related to enhancing tax treatment of long-term care insurance; issues related to qualified small employer health reimbursement accounts (QSEHRAs); issues related to implementation of the excise tax on high cost employer-sponsored health coverage; and other issues relating to health care reform implementation.
Client expense: $2,230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
2020 · third_quarter · Consumer Issues/Safety/Products
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, the Heroes Act The HEALS Act (Senate proposed legislation)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · third_quarter · Taxation/Internal Revenue Code
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, the Heroes Act The HEALS Act (Senate proposed legislation)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · third_quarter · Consumer Issues/Safety/Products
H.R. 457, Health Savings Account Act H.R. 603, Heath Savings Account Expansion Act H.R. 748, Middle Class Health Benefits Tax Repeal Act of 2019 H.R. 908, Stop Penalizing Work Seniors Act Green Amendment to H.R. 1500, Consumers First Act H.R. 1679, PHIT Act of 2019 H.R. 1922, Restoring Access to Medication Act of 2019 S. 1948 / H.R. 3709, Chronic Disease Management Act of 2019 H.R. 2108, Retirement Freedom Act H.R. 2163, Freedom for Families Act H.R. 2177, Faith in Health Savings Act of 2019 H.R. 3708, Primary Care Enhancement Act of 2019 H.R. 3796, Health Savings for Senior Act H.R. 3594, Healthcare Freedom Act H.R. 4130, Keeping HSAs Accessible Act of 2019 H.R. 4530, Native American Health Savings Improvement Act H.R. 5050, Veterans and Consumers Fair Credit Act H.R. 5332, the Protecting Your Credit Score Act of 2019 S. 12, Health Savings Act of 2019 S. 680, PHIT Act of 2019 S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 1030, Retirement Freedom Act S. 1089, Restoring Access to Medication Act S. 2440, Qualified Health Savings Account Distribution Act of 2019 S. 2441, Health Savings Account Expansion Act of 2019 S. 3112, Personalized Care Act of 2019 S. 3439, Lower Health Insurance Deductibles Act S. 3546/ H.R. 6338, Pandemic Healthcare Access Act S. 4039, To amend the Internal Revenue Code of 1986 to make permanent the permissible first-dollar coverage of telehealth services for purposes of health savings accounts. H.R. 5566, Patient Fairness Act of 2020 Sections 1776 and 1812 of H.R. 6395, William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client expense: $2,930,000 · Firm income: Not reported
2020 · second_quarter · Health Issues
H.R. 748, CARES Act H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R.1730, Cancer Drug Parity Act of 2019 H.R. 4100: DISARM Act of 2019 - Provisions related to antimicrobial drug development H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency S1872/HR5076, Protecting Seniors Through Immunization Act H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6258: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity H.R. 6260: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavi-rus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act H.R. 6450: Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6457: Disaster and Emergency Pricing Abuse Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6472: COVID-19 Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing HR6711, Medical Supply Transparency and Delivery Act, DPA impact on Rx manufacturers H.R. 6906: Health Care Emergency Guarantee Act - Provisions related to prescription drug access and cost sharing H.R. 7269: To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes - Provisions related to FDA provisional approval pathways H.R. 7288: To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development related to COVID-19, and for other purposes - Provisions related to prescription drug research and development and transparency H.R. 7296: To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes - Provisions related to prescription drug pricing and transparency S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 658: Accelerated Drug Approval for Prescription Therapies Act or the ADAPT Act - Provisions related to accelerated approval S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1712: DISARM Act of 2019 - Provisions related to antimicrobial drug development S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3545: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Corona-virus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals S3780, HOME Act S. 3872: Promising Pathway Act - Provisions related to FDA provisional approval pathways Transparency policy issues S. 3932: A bill to direct the Secretary of Defense to carry out a pilot program under the TRICARE pharmacy benefits program - Provisions related to DoD TRICARE pharmacy benefits program S. 4010: A bill to amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases - Provisions related to priority review vouchers H.R. 7288: Taxpayer Research and Coronavirus Knowledge (TRACK) Act of 2020 - Provisions related to database of federal biomedical investment information for COVID-19 H.R. 7296: Make Medicines Affordable by Preventing Pandemic Pricegouging (MMAPPP) Act of 2020 Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020 (discussion draft) Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (June 22, 2020) Department of Homeland Security cybersecurity policy issues HHS PREP Act declaration relating to COVID-19 Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors FDA modernization policy issues PDUFA policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients CARES ACT-Monograph Reform Support for Arthritis Caucus
2020 · second_quarter · Taxation/Internal Revenue Code
H.R. 3709 - Chronic Disease Management Act of 2019 - Blumenauer - HSAs and HDHPs H.R. 4651 - American Future Healthcare Act of 2019 - King - amends the Internal Revenue Code to expand health savings accounts H.R. 4652 - Individual Health Insurance Marketplace Improvement Act - Langevin - Individual Market Reinsurance fund H.R. 5807 - Know Your Provider Act of 2020 - Larson - provider directory information H.R. 5809 - Better Information Act of 2020 - Beyer - health insurance membership card H.R. 5816 - Continuing Care for Patients Act of 2020 - Moore - coverage and provider network status H.R. 5817 - Fair and Honest Advance Cost Estimate for Patients Act of 2020 - Nunes - health plan transparency H.R. 5825 - To amend the Internal Revenue Code of 1986 to provide for reporting by certain investors with respect to certain specified medical care providers - Neal - investment in medicine H.R. 6286 - Health Savings Act of 2020 - Burgess - health savings account H.R. 6545 - Health Insurance Marketplace Affordability Act of 2020 - Murphy H.R. 7008 - Family Savings Flexibility Act - Wenstrup - HSA arrangements S. 3439 - Lower Health Insurance Deductibles Act - Scott - health savings accounts S. 3539 - A bill to amend the Internal Revenue Code of 1986 to exempt telehealth services from certain high deductible health plan rules - Daines - telehealth S. 3546 - A bill to waive high deductible health plan requirements for health savings accounts - Cruz - health savings accounts S. 3924 - A bill to provide tax credits to low- to moderate-income individuals for certain computer and education costs, to direct the Federal Communications Commission to modify the requirements for the Lifeline program to provide increased support, and for other purposes. - Durbin - Lifeline/Medicaid Regulatory Issues: Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate; W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; health insurer and employer reporting of health coverage; issues related to implementation of health insurance tax; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to Patient-Centered Outcomes Research Institute (PCORI) re-authorization; issues related to enhancing tax treatment of long-term care insurance; issues related to qualified small employer health reimbursement accounts (QSEHRAs); issues related to implementation of the excise tax on high cost employer-sponsored health coverage; and other issues relating to health care reform implementation.
2020 · second_quarter · Health Issues
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 4100: DISARM Act of 2019 - Provisions related to antimicrobial drug development H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6258: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity H.R. 6260: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals H.R. 6390: Medical Supply Chain Emergency Act of 2020 - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act H.R. 6450: Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6457: Disaster and Emergency Pricing Abuse Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6472: COVID-19 Price Gouging Prevention Act - Provisions related to prescription drug and medical device pricing H.R. 6906: Health Care Emergency Guarantee Act - Provisions related to prescription drug access and cost sharing H.R. 7269: To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes - Provisions related to FDA provisional approval pathways H.R. 7288: Taxpayer Research and Coronavirus Knowledge Act of 2020 - Provisions related to prescription drug research and development and transparency H.R. 7296: MMAPPP Act of 2020 - Provisions related to prescription drug pricing and transparency S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 658: Accelerated Drug Approval for Prescription Therapies Act or the ADAPT Act - Provisions related to accelerated approval S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1712: DISARM Act of 2019 - Provisions related to antimicrobial drug development S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3545: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 - Provisions related to FDA prescription drug marketing approvals S. 3872: Promising Pathway Act - Provisions related to FDA provisional approval pathways S. 3932: TRICARE Retail Pharmacy Prescription Medication Expansion Act of 2020 - Provisions related to DoD TRICARE pharmacy benefits program S. 4010: Creating Hope Reauthorization Act - Provisions related to priority review vouchers Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020 (discussion draft) Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak (June 22, 2020) Department of Homeland Security cybersecurity policy issues HHS PREP Act declaration relating to COVID-19 Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance (AMR) policy issues High deductible health plans/HSA policy issues FDA modernization policy issues PDUFA policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Regulatory efficiencies policy issues COVID-19 policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients
2020 · second_quarter · Consumer Issues/Safety/Products
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1922, The Restoring Access to Medication Act of 2019 S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · second_quarter · Taxation/Internal Revenue Code
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1922, The Restoring Access to Medication Act of 2019 S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · second_quarter · Consumer Issues/Safety/Products
H.R. 457, Health Savings Account Act H.R. 603, Heath Savings Account Expansion Act H.R. 748, Middle Class Health Benefits Tax Repeal Act of 2019 H.R. 908, Stop Penalizing Work Seniors Act Green Amendment to H.R. 1500, Consumers First Act H.R. 1679, PHIT Act of 2019 H.R. 1922, Restoring Access to Medication Act of 2019 S. 1948 / H.R. 3709, Chronic Disease Management Act of 2019 H.R. 2108, Retirement Freedom Act H.R. 2163, Freedom for Families Act H.R. 2177, Faith in Health Savings Act of 2019 H.R. 3708, Primary Care Enhancement Act of 2019 H.R. 3796, Health Savings for Senior Act H.R. 3594, Healthcare Freedom Act H.R. 4130, Keeping HSAs Accessible Act of 2019 H.R. 4530, Native American Health Savings Improvement Act H.R. 5050, Veterans and Consumers Fair Credit Act H.R. 5332, the Protecting Your Credit Score Act of 2019 S. 12, Health Savings Act of 2019 S. 680, PHIT Act of 2019 S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 1030, Retirement Freedom Act S. 1089, Restoring Access to Medication Act S. 2440, Qualified Health Savings Account Distribution Act of 2019 S. 2441, Health Savings Account Expansion Act of 2019 S. 3112, Personalized Care Act of 2019 S. 3439, Lower Health Insurance Deductibles Act S. 3546/ H.R. 6338, Pandemic Healthcare Access Act S. 4039, To amend the Internal Revenue Code of 1986 to make permanent the permissible first-dollar coverage of telehealth services for purposes of health savings accounts. H.R. 5566, Patient Fairness Act of 2020
Client expense: $2,730,000 · Firm income: Not reported
2020 · first_quarter · Health Issues
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 1093: Stop Price Gouging Act - Provisions related to prescription drug pricing H.R. 1323: Rural Hospital Frontier Fairness Act - Provisions related to the 340B drug discount program H.R. 2296: FAIR Drug Pricing Act of 2019 / More Efficient Tools to Realize Information for Consumers Act - Provisions related to prescription drug pricing and transparency H.R. 2376: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers H.R. 4812: Ensuring Compliance Against Drug Diversion Act of 2019 - Provisions related to registrations under the Controlled Substances Act H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6173: Covering Coronavirus Test Act of 2020 - Provisions related to medical device pricing and coverage H.R. 6213: No Cost for COVID-19 Testing Act - Provisions related to medical device pricing and coverage H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6253: To expand certain securities exemptions to respond to COVID-19, to establish an X-prize for creating an effective COVID-19 vaccine, and for other purposes - Provisions related to prescription drug research and development H.R. 6261: To provide for coverage of testing for COVID-19 at no cost sharing for Indians receiving health services through the Indian Health Service, and for other purposes - Provisions related to medical device pricing and coverage H.R. 6264: To prohibit price gouging during a state of emergency declaration, and for other purposes - Provisions related to prescription drug and medical device pricing H.R. 6351: To authorize the Secretary of Health and Human Services to administer vaccinations for COVID-19, once available, at no cost to the inoculated, in response to the COVID-19 outbreak, and for other purposes - Provisions related to prescription drug patient access and cost sharing H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 - Provisions related to increases in the wholesale acquisition costs of prescription drugs S. 637: Combatting Unreasonable Rises and Excessively (CURE) High Drug Prices Act - Provisions related to prescription drug pricing and transparency S. 657: Drug Price Transparency Act - Provisions related to prescription drug pricing transparency and commercial market rebates S. 660: Efficiency and Transparency in Petitions Act - Provisions related to the FDA citizen petition process S. 801: Payment Commission Data Act of 2019 - Provisions related to prescription drug pricing transparency S. 977: Transparent Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and foreign reference pricing S. 1089: Restoring Access to Medication Act of 2019 - Provisions related to prescription drug access S. 1227: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1567: Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2019 - Provisions related to rare disease research and funding S1872/HR5076 Protecting Seniors Through Immunization Act S. 1897: A bill to establish a process for updating the labeling of certain drugs with outdated labeling - Provisions related to prescription drug labeling S. 2004: Emergency Access to Insulin Act of 2019 - Provisions related to prescription drug pricing S. 2103: Affordable Insulin Approvals Now Act - Provisions related to FDA prescription drug approvals S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 2897: Patient-Centered Outcomes Research Institute Reauthorization Act - Provisions related to PCORI reauthorization S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3180: Responsibility in Drug Advertising Act of 2020 - Provisions related to prescription drug direct-to-consumer advertising S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3442: Care for COVID-19 Act - Provisions related to prescription drug pricing and access S. 3499: A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Provisions related to medical device pricing and access S. 3505: A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Provisions related to prescription drug pricing and access S. 3545: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes - Provisions related to FDA prescription drug marketing approvals S. 3564: A bill to amend title XIX of the Social Security Act to require States to provide medical assistance for COVID-19 treatment services for individuals who are diagnosed with COVID-19, and for other purposes - Provisions related to prescription drug pricing and access S. 3570: A bill to provide for the expedited procurement of equipment needed to combat COVID-19 under the Defense Production Act of 1950 - Provisions related to the Defense Production Act Transparency policy issues Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues Monograph Reform CDC Programmatic Funding Restoration of HSA/FSAs 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Cancer drug vial size policy issues Drug shortages policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients
2020 · first_quarter · Taxation/Internal Revenue Code
H.R. 3709 - Chronic Disease Management Act of 2019 - Blumenauer - HSAs and HDHPs H.R. 4651 - American Future Healthcare Act of 2019 - King - amends the Internal Revenue Code to expand health savings accounts H.R. 4652 - Individual Health Insurance Marketplace Improvement Act - Langevin - Individual Market Reinsurance fund H.R. 5807 - Know Your Provider Act of 2020 - Larson - provider directory information H.R. 5809 - Better Information Act of 2020 - Beyer - health insurance membership card H.R. 5816 - Continuing Care for Patients Act of 2020 - Moore - coverage and provider network status H.R. 5817 - Fair and Honest Advance Cost Estimate for Patients Act of 2020 - Nunes - health plan transparency H.R. 5825 - To amend the Internal Revenue Code of 1986 to provide for reporting by certain investors with respect to certain specified medical care providers - Neal - investment in medicine H.R. 6286 - Health Savings Act of 2020 - Burgess - health savings account S. 3439 - Lower Health Insurance Deductibles Act - Scott - health savings accounts S. 3539 - A bill to amend the Internal Revenue Code of 1986 to exempt telehealth services from certain high deductible health plan rules - Daines - telehealth S. 3546 - A bill to waive high deductible health plan requirements for health savings accounts - Cruz - health savings accounts Regulatory Issues: Annual insurer provider fees; issues concerning the patient-centered outcomes research fee; employer coverage mandate; W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; health insurer and employer reporting of health coverage; issues related to implementation of health insurance tax; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to Patient-Centered Outcomes Research Institute (PCORI) re-authorization; issues related to enhancing tax treatment of long-term care insurance; issues related to qualified small employer health reimbursement accounts (QSEHRAs); issues related to implementation of the excise tax on high cost employer-sponsored health coverage; and other issues relating to health care reform implementation.
2020 · first_quarter · Health Issues
H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 1093: Stop Price Gouging Act - Provisions related to prescription drug pricing H.R. 1323: Rural Hospital Frontier Fairness Act - Provisions related to the 340B drug discount program H.R. 2296: FAIR Drug Pricing Act of 2019 / More Efficient Tools to Realize Information for Consumers Act - Provisions related to prescription drug pricing and transparency H.R. 2376: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers H.R. 4812: Ensuring Compliance Against Drug Diversion Act of 2019 - Provisions related to registrations under the Controlled Substances Act H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5382: To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices. - Provisions related to prescription drug pricing H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6173: Covering Coronavirus Test Act of 2020 - Provisions related to medical device pricing and coverage H.R. 6213: No Cost for COVID-19 Testing Act - Provisions related to medical device pricing and coverage H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6253: To expand certain securities exemptions to respond to COVID-19, to establish an X-prize for creating an effective COVID-19 vaccine, and for other purposes - Provisions related to prescription drug research and development H.R. 6261: To provide for coverage of testing for COVID-19 at no cost sharing for Indians receiving health services through the Indian Health Service, and for other purposes - Provisions related to medical device pricing and coverage H.R. 6264: To prohibit price gouging during a state of emergency declaration, and for other purposes - Provisions related to prescription drug and medical device pricing H.R. 6351: To authorize the Secretary of Health and Human Services to administer vaccinations for COVID-19, once available, at no cost to the inoculated, in response to the COVID-19 outbreak, and for other purposes - Provisions related to prescription drug patient access and cost sharing H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 - Provisions related to increases in the wholesale acquisition costs of prescription drugs S. 637: Combatting Unreasonable Rises and Excessively (CURE) High Drug Prices Act - Provisions related to prescription drug pricing and transparency S. 657: Drug Price Transparency Act - Provisions related to prescription drug pricing transparency and commercial market rebates S. 660: Efficiency and Transparency in Petitions Act - Provisions related to the FDA citizen petition process S. 801: Payment Commission Data Act of 2019 - Provisions related to prescription drug pricing transparency S. 977: Transparent Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and foreign reference pricing S. 1089: Restoring Access to Medication Act of 2019 - Provisions related to prescription drug access S. 1227: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1567: Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2019 - Provisions related to rare disease research and funding S. 1897: A bill to establish a process for updating the labeling of certain drugs with outdated labeling - Provisions related to prescription drug labeling S. 2004: Emergency Access to Insulin Act of 2019 - Provisions related to prescription drug pricing S. 2103: Affordable Insulin Approvals Now Act - Provisions related to FDA prescription drug approvals S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 2897: Patient-Centered Outcomes Research Institute Reauthorization Act - Provisions related to PCORI reauthorization S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3180: Responsibility in Drug Advertising Act of 2020 - Provisions related to prescription drug direct-to-consumer advertising S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3442: Care for COVID-19 Act - Provisions related to prescription drug pricing and access S. 3468 Preventing Essential Medical Device Shortages Act of 2020 - Provisions related to medical device shortage reporting requirements S. 3499: A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Provisions related to medical device pricing and access S. 3505: A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Provisions related to prescription drug pricing and access S. 3545: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes - Provisions related to FDA prescription drug marketing approvals S. 3564: A bill to amend title XIX of the Social Security Act to require States to provide medical assistance for COVID-19 treatment services for individuals who are diagnosed with COVID-19, and for other purposes - Provisions related to prescription drug pricing and access S. 3568: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act S. 3570: A bill to provide for the expedited procurement of equipment needed to combat COVID-19 under the Defense Production Act of 1950 - Provisions related to the Defense Production Act Transparency policy issues Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Antimicrobial resistance policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Cancer drug vial size policy issues Drug shortages policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients
2020 · first_quarter · Consumer Issues/Safety/Products
H.R. 457, Health Savings Account Act H.R. 603, Heath Savings Account Expansion Act H.R. 748, Middle Class Health Benefits Tax Repeal Act of 2019 H.R. 908, Stop Penalizing Work Seniors Act Green Amendment to H.R. 1500, Consumers First Act H.R. 1679, PHIT Act of 2019 H.R. 1922, Restoring Access to Medication Act of 2019 S. 1948 / H.R. 3709, Chronic Disease Management Act of 2019 H.R. 2108, Retirement Freedom Act H.R. 2163, Freedom for Families Act H.R. 2177, Faith in Health Savings Act of 2019 H.R. 3708, Primary Care Enhancement Act of 2019 H.R. 3796, Health Savings for Senior Act H.R. 3594, Healthcare Freedom Act H.R. 4130, Keeping HSAs Accessible Act of 2019 H.R. 4530, Native American Health Savings Improvement Act H.R. 5050, Veterans and Consumers Fair Credit Act H.R. 5332, the Protecting Your Credit Score Act of 2019 S. 12, Health Savings Act of 2019 S. 680, PHIT Act of 2019 S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 1030, Retirement Freedom Act S. 1089, Restoring Access to Medication Act S. 2440, Qualified Health Savings Account Distribution Act of 2019 S. 2441, Health Savings Account Expansion Act of 2019 S. 3112, Personalized Care Act of 2019 S. 3439, Lower Health Insurance Deductibles Act H.R. 5566, Patient Fairness Act of 2020
Client expense: $2,400,000 · Firm income: Not reported
2020 · first_quarter · Taxation/Internal Revenue Code
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1922, The Restoring Access to Medication Act of 2019 S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
2020 · first_quarter · Consumer Issues/Safety/Products
Health Savings Account issues Health Savings Act of 2019 - S. 12 Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Health Savings Account Act -- H.R. 457 Health Savings Account Expansion Act of 2019 -- H.R. 603 Stop Penalizing Working Seniors Act -- H.R. 908 Primary Care Enhancement Act -- H.R. 3708 Health Savings for Seniors Act -- H. R. 3796 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1922, The Restoring Access to Medication Act of 2019 S. 3439, the Lower Health Insurance Deductibles Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)
Client expense: Not reported · Firm income: $20,000
Government targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Client expense: $2,250,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
Client expense: $5,410,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Client expense: $940,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Client expense: $3,630,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
Client expense: $9,020,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of